Skip to main content

Olanzapine Injection Shortage

Last Updated: January 24, 2017
Status: Resolved

Products Affected - Description
    • Olanzapine intramuscular injection, American Regent, 10 mg, vial, 1 count, NDC 00517-0955-01
Reason for the Shortage
    • American Regent cannot provide a reason for the shortage.
    • Sandoz had olanzapine injection on shortage due to increase demand.
Available Products
    • Zyprexa intramuscular injection, Lilly USA, LLC, 10 mg, vial, 1 count, NDC 00002-7597-01
    • Olanzapine intramuscular injection, Sandoz, 10 mg, vial, 1 count, NDC 00781-3159-72

Estimated Resupply Dates

    • American Regent has olanzapine 10 mg vials on back order and the company cannot estimate a release date.


Updated January 24, 2017 by Elyse MacDonald, PharmD, MS, BCPS. Created March 14, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.